The University of North Carolina at Chapel Hill (UNC-CH) received a $1,541,280 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to fund "The Breast Cancer Cellular Atlas" project. This 4-year award, effective March 1, 2025, supports innovative biomedical research aimed at improving health outcomes for military service members and the broader public. As a major public research university with extensive experience managing large federal awards, UNC-CH will leverage its broad academic and research capabilities to conduct basic, applied, and advanced studies related to breast cancer. The award will enable UNC-CH, potentially in collaboration with other research institutions, to deliver research products and services such as developing new treatments, exploring novel therapeutic approaches like gene therapy and immunological interventions, and conducting clinical trials.
Generated 3/4/25, 5:15 AM